DRONABINOL

Course overview

DRONABINOL IS SYNTHETIC TETRAHYDROCANNABINOL ('THC'), WHICH OBTAINED FDA APPROVAL IN 1985 FOR THE TREATMENT OF HIV/AIDS-INDUCED ANOREXIA AND CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WHO HAVE FAILED TO RESPOND TO CONVENTIONAL ANTIEMETICS. DRONABINOL HAS ALSO BEEN USED OFF-LABEL FOR THE TREATMENT OF OSA. THIS ACTIVITY WILL PROVIDE AN OVERVIEW OF THE PHARMACOLOGY OF DRONABINOL, ITS INDICATIONS AND USAGE, ADVERSE EFFECTS, CONTRAINDICATIONS, AND OTHER PERTINENT INFORMATION.